It was found that the mutant ASXL1 protein with c-terminal truncation was expressed at a much higher level in ASXL1 heterozygous leukemia cells than the wild-type protein and lost its ability to interact with FoxK1/2. This evidence concerns the gene ASXL1 and leukemia.